Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity

Stephen B. Heitner, Jessica Minnier, Aynun Naher, Ryan C. Van Woerkom, Alexandra Ritts, Maros Ferencik, Craig Broberg, Eva Medvedova, Rebecca Silbermann, Emma C. Scott

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bortezomib-based Chemotherapy for Multiple Myeloma Patients Without Comorbid Cardiovascular Disease Shows No Cardiotoxicity'. Together they form a unique fingerprint.

Medicine & Life Sciences